米非司酮与腹腔镜子宫肌瘤剔除术治疗子宫肌瘤的临床效果比较

Abstract
Figure/Table
References (17)
Related Citation (15)

Download: PDF (0 KB) HTML (35 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To study the clinical effect of Mifepristone and laparoscopic myomectomy for uterine fibroids.Methods A total of 64 patients with uterine fibroids received treatment in our hospital from February to December 2017 were selected.They were divided into group A (Mifepristone group)and group B (laparoscope group)through the random number table method,32 cases in each group.Patients in group A were treated with Mifepristone,and hysteromyomectomy was performed under laparoscope in group B patients.The total efficiency,quality of life of the two groups were observed and recorded.Results The total effective rate in group A was 78.1%,and the total effective rate was 93.8%in group B,and the difference between the two groups was statistically significant(P＜0.05).The emotional function of patients of group A was obviously higher than that of group B patients,the difference was statistically significant(P＜0.05),whereas physical function，cognitive function,physical health,social function and role function of group B was better than that in group A of patients,patients with statistically significant difference (P＜0.05).Conclusion Compared with mifepristone,laparoscopic myomectomy has a high success rate,and good clinical effect.However,the use of Mifepristone for drug therapy has the ability to significantly improve the patient′s prognosis.

Key words： Mifepristone Laparoscope Hysteromyomectomy Uterine fibroids

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	LIN Qi-yu

Cite this article:

LIN Qi-yu. Comparison of clinical efficacy of Mifepristone and laparoscopic myomectomy treating uterine fibroids[J]. 中国当代医药, 2018, 25(19): 107-109.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2018/V25/I19/107

[1]	孙建华，毕进霞.米非司酮在子宫肌瘤剔除术后预防复发的效果观察[J].中国农村卫生，2017，（22）：91-92.
[2]	李海玲.米非司酮对行腹腔镜子宫肌瘤剔除术的临床观察[J].现代诊断与治疗，2017，28（14）：2590-2591.
[3]	崔楠.米非司酮在子宫肌瘤剔除术后治疗中的应用分析[J].中国当代医药，2016，23（35）：105-107.
[4]	张建红，杨宝珍，胡玉玲，等.腹腔镜下子宫肌瘤剔除术与开腹子宫肌瘤剔除术的对比研究[J].医学综述，2013，19（6）：3066-3068.
[5]	刘燕美.米非司酮预处理在腹腔镜子宫肌瘤剔除术中的应用价值[J].深圳中西医结合杂志，2016，26（17）：68-69.
[6]	叶明珠，邓新粮，薛敏.围绝经期子宫肌瘤的处理[J].中国实用妇科与产科杂志，2016，32（2）：126-131.
[7]	李龙，王月玲.腹腔镜下子宫肌瘤剔除术与开腹手术的临床疗效对比[J].中国肿瘤临床与康复，2012，19（4）：363-364.
[8]	时欣欣.腹腔镜子宫肌瘤剔除术前米非司酮预处理的临床效果观察[J].河南医学研究，2016，25（3）：552-553.
[9]	谢秋菊.米非司酮在子宫肌瘤剔除术后治疗中的疗效观察[J].实用妇科内分泌杂志（电子版），2016，3（4）：38-39.
[10]	潘雪梅.子宫肌瘤剔除术后米非司酮预防肌瘤复发的临床分析[J].中国当代医药，2010，17（10）：13-14.
[11]	郑素红.米非司酮在子宫肌瘤剔除术后60例中的应用[J].中国民族民间医药，2015，24（19）：90-91.
[12]	刘维娜.术前应用米非司酮片对子宫肌瘤手术的影响[J].河北中医，2015，37（9）：1438-1440.
[13]	劳佩维，李梅，白延青，等.米非司酮用于腹腔镜下多发性子宫肌瘤剔除术后的临床价值[J].现代实用医学，2009，21（4）：358-359.
[14]	罗红琳.腹腔镜下子宫肌瘤剔除术和开腹子宫肌瘤剔除术的比较研究[J].微创医学，2012，7（2）：146-147.
[15]	李龙，王月玲.腹腔镜下子宫肌瘤剔除术与开腹手术的临床疗效对比[J].中国肿瘤临床与康复，2012，19（4）：363-364.
[16]	韩兆忠，刘茜，郑伟然，等.桂枝茯苓胶囊联合米非司酮治疗子宫肌瘤临床疗效和安全性的系统性评价[J].世界科学技术（中医药现代化），2016，18（3）：543-551.
[17]	方海娅，张海燕，寿华锋.米非司酮治疗围绝经期子宫肌瘤的临床研究[J].中国临床药理学杂志，2016，32（11）：987-989.